These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 7007059)
1. Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline. Zamboulis C; Reid JL Eur J Clin Pharmacol; 1981 Jan; 19(1):19-24. PubMed ID: 7007059 [TBL] [Abstract][Full Text] [Related]
2. Guanfacine: effects of long-term treatment and withdrawal. Reid JL; Zamboulis C; Hamilton CA Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774 [TBL] [Abstract][Full Text] [Related]
3. Effects of single and multiple doses of guanfacine in essential hypertension. Zamboulis C; Reid JL Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428 [TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension. Nami R; Bianchini C; Fiorella G; Chierichetti SM; Gennari C J Cardiovasc Pharmacol; 1983; 5(4):546-51. PubMed ID: 6193349 [TBL] [Abstract][Full Text] [Related]
5. Guanfacine and other centrally acting drugs in antihypertensive therapy; pharmacological and clinical aspects. Saameli K; Jerie P; Scholtysik G Clin Exp Hypertens A; 1982; 4(1-2):209-19. PubMed ID: 6280899 [TBL] [Abstract][Full Text] [Related]
6. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Sorkin EM; Heel RC Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177 [TBL] [Abstract][Full Text] [Related]
7. Clonidine and guanfacine in hypertension. Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307 [TBL] [Abstract][Full Text] [Related]
8. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension. Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530 [TBL] [Abstract][Full Text] [Related]
9. Long-term antihypertensive therapy with guanfacine. Szám I; Holló J Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effect of guanfacine: long-term 'once-a-day' treatment and sudden withdrawal. Szám I; Holló J Clin Sci (Lond); 1981 Dec; 61 Suppl 7():469s-471s. PubMed ID: 7032828 [TBL] [Abstract][Full Text] [Related]
12. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension. Manhem P; Hökfelt B Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763 [No Abstract] [Full Text] [Related]
13. Effects of abrupt cessation of treatment with clonidine and guanfacine on blood pressure and heart rate in spontaneously hypertensive rats. Koike Y; Togashi H; Shimamura K; Yomaida I; Saito H Clin Exp Hypertens (1978); 1981; 3(1):103-20. PubMed ID: 7009101 [TBL] [Abstract][Full Text] [Related]
14. The antihypertensive effect of guanfacine compared with methyldopa. van der Merwe CJ; Kruger SA S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713 [TBL] [Abstract][Full Text] [Related]
15. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension. Collart F; Staroukine M; Verniory A Acta Cardiol; 1985; 40(3):269-76. PubMed ID: 3895792 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of guanfacine and clonidine in essential hypertension: a single-blind crossover study. Miach PJ; Louis WJ Med J Aust; 1980 Oct; 2(7):395-6. PubMed ID: 7005630 [TBL] [Abstract][Full Text] [Related]